Stanford medical student Nathan Lo reportedly caused a stir at the Conference on Retroviruses and Opportunistic Infections (CROI) last week when he presented a new finding: After analyzing surveys completed by 800,000 people in 22 sub-Saharan African countries, Lo and his colleagues found “no evidence to suggest that PEPFAR funding of abstinence and faithfulness programs results in reduced high-risk sexual behavior.”
Last week, FDA warned healthcare providers that the complex design of a piece of endoscopy eqiupment may make it hard to fully disinfect — which means that using it, even in accordance with the manufacturers’ instructions, might allow dangerous bacteria to spread between patients.
Last week, US Representative Rosa DeLauro (D-CT) and Senator Patty Murray (D-WA) reintroduced the Healthy Families Act, which would allow US workers to earn paid sick time.
After the Colorado Family Planning Initiative (CFPI) started providing free IUDs and implants to low-income women at family planning clinics, the teen birth rate and abortion rate dropped sharply.
Recent pieces address the toll of measles; evidence vs. hype in treating heroin addiction; why foodborne-illness outbreaks linked to poultry keep happening; and more.
In the week before his 2015 State of the Union address, President Obama took modest but important steps toward expanding US workers’ access to paid sick and family leave.
Poverty rates are rising in many suburban areas, but suburban public transit systems are often inadequate for low-income residents trying to get to work.
US children have three main routes to health-insurance coverage, but the “family glitch” leaves some families without an affordable insurance option.
Last week, the US Food and Drug Administration published a final rule that updates requirements for what prescription-drug information must disclose about potential effects for pregnant and breastfeeding women and their babies. And last month, the agency released Drug Trials Snapshots, which is part of a pilot project to help consumers learn more about the clinical trials upon which new drugs’ approvals are based.